MDPI and ACS Style
Lebouvier, N.; Pagniez, F.; Na, Y.M.; Shi, D.; Pinson, P.; Marchivie, M.; Guillon, J.; Hakki, T.; Bernhardt, R.; Yee, S.W.;
et al. Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols. Pharmaceuticals 2020, 13, 186.
https://doi.org/10.3390/ph13080186
AMA Style
Lebouvier N, Pagniez F, Na YM, Shi D, Pinson P, Marchivie M, Guillon J, Hakki T, Bernhardt R, Yee SW,
et al. Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols. Pharmaceuticals. 2020; 13(8):186.
https://doi.org/10.3390/ph13080186
Chicago/Turabian Style
Lebouvier, Nicolas, Fabrice Pagniez, Young Min Na, Da Shi, Patricia Pinson, Mathieu Marchivie, Jean Guillon, Tarek Hakki, Rita Bernhardt, Sook Wah Yee,
and et al. 2020. "Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols" Pharmaceuticals 13, no. 8: 186.
https://doi.org/10.3390/ph13080186